Loading institutional data...
Loading institutional data...
Held by 119 of 2,417 reporting institutions (91th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 10 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MET | $64.1B | 21.4× | 6.8× | 0.8× | 8.6% | — | 4.4% | 11.9% | 11.8% | -3.5× | 461 |
| RGA | $17.2B | 14.9× | — | 0.7× | 7.2% | — | 5.0% | 8.8% | 6.2% | — | 159 |
| GL | $12.3B | 11.4× | — | 2.1× | 3.7% | — | 19.4% | 19.4% | 13.5% | — | 166 |
| VOYA | $8.9B | 15.6× | — | 1.1× | 1.7% | — | 8.0% | 13.2% | 9.3% | — | 104 |
| PRI | $8.7B | 12.4× | — | 2.6× | 6.6% | — | 22.8% | 30.7% | 30.7% | — | 123 |
| LNC | $7.9B | 7.1× | — | 0.4× | -1.2% | — | 6.5% | 10.8% | 6.9% | — | 156 |
| PFH | $5.3B | 1.5× | — | 0.1× | -13.7% | — | 5.9% | 11.0% | 6.8% | — | — |
| GNW | $3.4B | 16.7× | — | 0.5× | 0.1% | — | 3.1% | 2.5% | 2.2% | — | 75 |
| FG | $2.8B | 11.2× | — | 0.5× | -0.2% | — | 4.6% | 5.5% | 3.8% | — | 83 |
| BHF | $2.5B | 7.5× | — | 0.4× | 43.2% | — | 6.4% | 6.4% | 4.4% | — | 119 |
| UTGN | $192M | 11.3× | — | 4.5× | -50.1% | — | 40.3% | 7.4% | 7.4% | — | — |
Peers = companies sharing BHF's sector (Life Insurance) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
No trend data available for this metric.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $102.0M buybacks = $102.0M returned on $259.0M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
A reverse discounted cash flow is not shown for an insurer.
Funded by policyholder float, not debt. Reserve adequacy and RBC are the right questions and are not collected yet.
Classified from the filings: SIC code.
Leverage ratios is not shown for an insurer.
Funded by policyholder float, not debt. Reserve adequacy and RBC are the right questions and are not collected yet.
Classified from the filings: SIC code.
How much the company owes, how it's trended, and how comfortably it's serviced.
$3.0M of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~4.8% on $3.15B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.77B 100.0% | $4.72B 100.0% | $4.12B 100.0% | $6.87B 100.0% | $4.98B 100.0% | $8.50B 100.0% | $6.55B 100.0% | $8.96B 100.0% | $6.84B 100.0% | $3.02B 100.0% |
| Total Operating Expenses | $1.96B 28.9% | $1.95B 41.2% | $1.98B 48.0% | $2.08B 30.3% | $2.45B 49.2% | $2.35B 27.7% | $2.49B 38.0% | $2.58B 28.7% | $2.48B 36.3% | $2.28B 75.7% |
| Interest Expense | $152.0M 2.2% | $152.0M 3.2% | $153.0M 3.7% | $153.0M 2.2% | $163.0M 3.3% | $184.0M 2.2% | $191.0M 2.9% | $158.0M 1.8% | $135.0M 2.0% | $133.0M 4.4% |
| Pretax Income | $474.0M 7.0% | $422.0M 8.9% | -$1.47B -35.8% | $4.73B 68.8% | $2.01B 40.4% | -$1.42B -16.7% | -$1.05B -16.1% | $989.0M 11.0% | -$615.0M -9.0% | -$4.71B -155.9% |
| Income Tax Expense | $36.0M 0.5% | $29.0M 0.6% | -$367.0M -8.9% | $848.0M 12.3% | $361.0M 7.3% | -$363.0M -4.3% | -$317.0M -4.8% | $119.0M 1.3% | -$237.0M -3.5% | -$1.77B -58.5% |
| Net Income | $331.0M 4.9% | $286.0M 6.1% | -$1.21B -29.5% | $3.77B 54.9% | $1.55B 31.2% | -$1.06B -12.5% | -$740.0M -11.3% | $865.0M 9.6% | -$378.0M -5.5% | -$2.94B -97.4% |
| Per Share | ||||||||||
| EPS (Basic) | $5.75 | $4.67 | -$18.39 | $51.73 | $18.54 | -$11.58 | -$6.76 | $7.24 | -$3.16 | -$24.54 |
| EPS (Diluted) | $5.71 | $4.64 | -$18.39 | $51.30 | $18.39 | -$11.58 | -$6.76 | $7.21 | -$3.16 | -$24.54 |
| Weighted Avg Shares (Basic) | 57.5M | 61.2M | 66.0M | 73.0M | 83.8M | 95.4M | 112.5M | 119.4M | 119.8M | 119.8M |
| Weighted Avg Shares (Diluted) | 57.9M | 61.6M | 66.0M | 73.6M | 84.5M | 95.4M | 112.5M | 119.8M | 119.8M | 119.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | — |
| 2026-06-02 | 5 co-filers Group filing | Option exercise | 1,418 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 4,556 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | — |
| 2026-06-02 | 5 co-filers Group filing | Option exercise | 1,418 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 4,556 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Option exercise | 2,837 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Grant | 2,651 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Grant | 2,651 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Grant | 2,651 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Grant | 4,257 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Grant | 2,651 | $0.00 | — |
| 2026-06-02 | 5 co-filers Group filing | Option exercise | 1,419 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Grant | 2,651 | $0.00 | — |
| 2026-06-02 | 3 co-filers Group filing | Grant | 2,651 | $0.00 | — |
| 2026-06-02 | 5 co-filers Group filing | Option exercise | 1,419 | $0.00 | — |
| 2026-06-02 | 5 co-filers Group filing | Grant | 2,651 | $0.00 | — |
| 2026-05-01 | 2 co-filers Group filing | Option exercise | 3,361 | $0.00 | $0 |
| 2026-05-01 | 4 co-filers Group filing | Option exercise | 1,120 | $0.00 | $0 |
| 2026-05-01 | 4 co-filers Group filing | Option exercise | 3,703 | $0.00 | $0 |
| 2026-05-01 | 2 co-filers Group filing | Option exercise | 3,361 | $0.00 | — |
| 2026-05-01 | 4 co-filers Group filing | Option exercise | 1,120 | $0.00 | — |
| 2026-05-01 | 4 co-filers Group filing | Option exercise | 3,703 | $0.00 | — |
| 2026-04-08 | 3 co-filers Chief Accounting Officer | Option exercise | 5,581 | — | — |
| 2026-04-08 | 3 co-filers Chief Accounting Officer | Tax withholding | 1,588 | $61.02 | $97k |
| 2026-04-08 | 3 co-filers Chief Accounting Officer | Option exercise | 5,581 | $0.00 | — |
| 2026-03-02 | 8 co-filers EVP & General Counsel | Option exercise | 7,072 | — | — |
| 2026-03-02 | 8 co-filers EVP, Chief Operating Officer | Option exercise | 9,420 | — | — |
| 2026-03-02 | 8 co-filers EVP & Chief HR Officer | Option exercise | 6,103 | — | — |
| 2026-03-02 | 8 co-filers Chief Accounting Officer | Option exercise | 1,383 | — | — |
| 2026-03-02 | 8 co-filers President and CEO | Option exercise | 35,564 | — | — |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
EOD close · as of 2026-10-30
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | -172.4% | -97.4% |
| FY2017 | not reported | -14.0% | -5.5% |
| FY2018 | not reported | 8.9% | 9.6% |
| FY2019 | not reported | not reported | -11.3% |
| FY2020 | not reported | not reported | -12.5% |
| FY2021 | not reported | not reported | 33.0% |
| FY2022 | not reported | not reported | 56.4% |
| FY2023 | not reported | not reported | -27.0% |
| FY2024 | not reported | not reported | 8.2% |
| FY2025 | not reported | not reported | 6.4% |
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Where each multiple sits in its own 9-yr range · 35th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 9-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 6% against ROIC 4% — 2% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Income Tax | 1.3 | -4.8 | -4.3 | 7.3 | 12.3 | -8.9 | 0.6 | 0.5 |
| Net Income | 9.6 | -11.3 | -12.5 | 31.2 | 54.9 | -29.5 | 6.1 | 4.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BHF: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Leverage and buybacks account for 2 points of the 6% return on equity in FY2025. The business earns 4% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
Free cash flow has fallen short of reported profit in 3 of the last three years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $433M | $433M |
| Share-based comp | $42M | $475M |
| Other non-cash & working capital | −$216M | $259M |
| Operating cash flow | $259M | $259M |
| Capex | $0 | $259M |
| Free cash flow | $259M | $259M |
| FCF after SBC | $217M | $217M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 29.7% | not reported | not reported |
| FY2021 | -41.5% | not reported | not reported |
| FY2022 | 38.1% | not reported | not reported |
| FY2023 | -40.1% | not reported | not reported |
| FY2024 | 14.7% | not reported | not reported |
| FY2025 | 43.2% | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -1.1 percent |
| FY2020 | -0.8 percent |
| FY2021 | 0.4 percent |
| FY2022 | 2.3 percent |
| FY2023 | -0.4 percent |
| FY2024 | 0.3 percent |
| FY2025 | 0.1 percent |
Reported free cash flow is $259M; after share-based compensation it is $217M. The difference is a real cost that the cash flow statement adds back.
Leverage is not measurable this way for a insurer.
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025. No cash figure on the matching balance sheet, so no coverage line is drawn.
Funded by policyholder float, not debt. Reserve adequacy and RBC are the right questions and are not collected yet.
Missing from our data, so excluded from this answer: capital adequacy metrics for this archetype.
At $42.98, free cash flow must compound 8.84%/yr for 10 years. It has done -27.8%/yr over 6 years, though across a reporting-basis change.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | −51.4% | 8.8% |
| FY2021 | −27.8% | 8.8% |
| FY2022 | −291.6% | 8.8% |
The achieved growth rate spans a reporting-basis change in FY2021, so part of it measures the restatement rather than the business.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.